Matsushita Makoto, Irino Tsutomu, Kamiyama Kiyoshi, Muramoto Yoshimi, Kawaguchi Takeshi, Nakano Takanari, Komoda Tsugikazu
Department of Clinical Chemistry, Saitama Prefectural University, 820 Sannomiya, Koshigaya 343-8540, Japan.
Ann Clin Biochem. 2007 Nov;44(Pt 6):544-8. doi: 10.1258/000456307782268165.
Intestinal alkaline phosphatase (IAP) isozymes in the healthy human serum samples appears in two isoforms: normal-molecular-weight IAP (NIAP) and high-molecular-weight IAP (HIAP). We have demonstrated that the reference range for serum alkaline phosphatase (ALP) activity is higher in blood group B and O antigen secretors than in the tested other blood groups, for the appearance of these isoforms is depended on blood group B or O antigen secretors.
We assessed a diethanolamine-L-phenylalanine (DEA-Phe) method for measuring tissue non-specific alkaline phosphatase (TNAP). This assays the sum of liver alkaline phosphatase and bone alkaline phosphatase activities as determined by an inhibiting IAP activity method with Phe. We classified 420 healthy subjects into two groups, a group of subjects who had blood group B or O antigen secretors (n = 184) and a group of subjects who had other blood groups (n = 236).
ALP activity was higher in the B or O secretor group than in the other group: 20.9% higher (P<0.001) by the N-methyl-D-glucamine method, 13.7% higher (P<0.002) by 2-amino-2-methyl-1-propanol method, and 9.6% higher (P<0.05) by the diethanolamine method, but there was no significant difference in TNAP activity between the two blood group when measured by the DEA-Phe method.
These results of this study support the expectation that the DEA-Phe method would be specific for TNAP activity. In addition, the reference range for TNAP activity did not vary with the differences in the tested all blood groups.
健康人血清样本中的肠道碱性磷酸酶(IAP)同工酶有两种亚型:正常分子量IAP(NIAP)和高分子量IAP(HIAP)。我们已经证明,B型血和O型血抗原分泌者的血清碱性磷酸酶(ALP)活性参考范围高于其他被检测血型,因为这些同工酶的出现取决于B型血或O型血抗原分泌者。
我们评估了一种二乙醇胺-L-苯丙氨酸(DEA-Phe)法用于测量组织非特异性碱性磷酸酶(TNAP)。该方法通过用苯丙氨酸抑制IAP活性的方法来测定肝碱性磷酸酶和骨碱性磷酸酶活性的总和。我们将420名健康受试者分为两组,一组是B型血或O型血抗原分泌者(n = 184),另一组是其他血型的受试者(n = 236)。
B型或O型分泌者组的ALP活性高于另一组:N-甲基-D-葡糖胺法高20.9%(P<0.001),2-氨基-2-甲基-1-丙醇法高13.7%(P<0.002),二乙醇胺法高9.6%(P<0.05),但用DEA-Phe法测量时,两组血型之间的TNAP活性没有显著差异。
本研究的这些结果支持了DEA-Phe法对TNAP活性具有特异性的预期。此外,TNAP活性的参考范围不会因所有被检测血型的差异而变化。